Stay updated on NasoVAX in Early COVID-19 Clinical Trial

Sign up to get notified when there's something new on the NasoVAX in Early COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the NasoVAX in Early COVID-19 Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.4.2 label and removal of a government funding status notice; neither affects the core study details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:19:48.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now includes a funding-status notice and an operation-status link at the top, and the revision tag was updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T00:28:29.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option to the page and updated the QC status label to 'Last Update Submitted that Met QC Criteria'. Standardized the 'No FEAR Act Data' capitalization and updated the page revision to v3.4.0 (from v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T00:19:37.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4; no substantive content changes to study details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:30:25.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The per-state 'X Locations' headers have been replaced with a consolidated 'Locations' section listing Florida, Georgia, Illinois, North Carolina, and Texas. This update, part of revision v3.3.3, changes the layout and presentation of site locations.
    Difference
    0.7%
    Check dated 2025-12-23T08:33:20.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The update consists of a site revision note (Revision: v3.3.2) replacing the previous v3.3.1; no changes to core study content or navigation evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:27:43.000Z thumbnail image

Stay in the know with updates to NasoVAX in Early COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the NasoVAX in Early COVID-19 Clinical Trial page.